$1.99B
Revenue
$651.95M
Net Income
82.23%
Gross Margin
46.45%
Op. Margin
$1.23B
Free Cash Flow
| Breakdown | Q4 2025 (Sep 30, 2025) |
Q3 2025 (Jun 30, 2025) |
Q2 2025 (Mar 31, 2025) |
Q1 2025 (Dec 31, 2024) |
Q4 2024 (Sep 30, 2024) |
Q3 2024 (Jun 30, 2024) |
Q2 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $515.75M | $536.41M | $498.74M | $439.97M | $453.81M | $447.85M | $433.81M |
| Revenue Growth % (YoY) | 13.6% | 19.8% | 15.0% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $91.18M | $87.57M | $87.63M | $87.34M | $89.57M | $88.22M | $86.95M |
| Gross Profit | $424.57M | $448.84M | $411.11M | $352.62M | $364.24M | $359.62M | $346.86M |
| Gross Margin % | 82.3% | 83.7% | 82.4% | 80.1% | 80.3% | 80.3% | 80.0% |
| Operating Expenses | $278.60M | $273.90M | $253.09M | $260.44M | $256.63M | $257.60M | $238.97M |
| Research & Development | $50.95M | $47.21M | $45.04M | $45.15M | $44.21M | $44.22M | $40.88M |
| Selling General & Admin | $125.54M | $139.11M | $120.42M | $127.95M | $122.76M | $124.88M | $110.87M |
| Operating Income | $237.16M | $262.52M | $245.65M | $179.53M | $197.18M | $190.25M | $194.84M |
| Operating Margin % | 46.0% | 48.9% | 49.3% | 40.8% | 43.4% | 42.5% | 44.9% |
| Interest Expense | $2.45M | $101.11M | $31.38M | $29.49M | $28.52M | $26.87M | $26.09M |
| Other Income/Expense | $5.18M | $7.37M | $-1.25M | $89.00K | $2.72M | $3.94M | $3.99M |
| Income Before Tax | $202.46M | $236.99M | $213.02M | $150.13M | $171.38M | $167.32M | $172.73M |
| Income Tax Expense | $47.45M | $55.20M | $50.40M | $-2.40M | $35.69M | $41.06M | $42.94M |
| Net Income | $155.01M | $181.79M | $162.62M | $152.53M | $135.69M | $126.26M | $129.80M |
| Net Margin % | 30.1% | 33.9% | 32.6% | 34.7% | 29.9% | 28.2% | 29.9% |
| Basic EPS | 6.49 | 7.49 | 6.67 | 6.26 | 5.54 | 5.12 | 5.23 |
| Diluted EPS | 6.42 | 7.40 | 6.59 | 6.14 | 5.44 | 5.05 | 5.16 |
| Basic Shares Outstanding | -111K | 24.3M | 24.4M | 24.4M | -67K | 24.6M | 24.8M |
| Diluted Shares Outstanding | -135K | 24.6M | 24.7M | 24.8M | -50K | 25.0M | 25.2M |
| Breakdown | Q4 2025 (Sep 30, 2025) |
Q3 2025 (Jun 30, 2025) |
Q2 2025 (Mar 31, 2025) |
Q1 2025 (Dec 31, 2024) |
Q4 2024 (Sep 30, 2024) |
Q3 2024 (Jun 30, 2024) |
Q2 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $134.14M | $189.05M | $146.64M | $184.25M | $150.67M | $156.04M | $135.67M |
| Accounts Receivable | $529.15M | $454.11M | $492.54M | $350.92M | $426.64M | $437.64M | $469.02M |
| Other Current Assets | $41.88M | $66.69M | $85.73M | $60.66M | $40.10M | $37.45M | $36.78M |
| Total Current Assets | $705.16M | $709.84M | $724.91M | $595.84M | $617.41M | $631.13M | $641.47M |
| Property Plant & Equipment | - | - | - | - | $38.47M | - | - |
| Goodwill | $783.34M | $785.45M | $779.28M | $775.55M | $782.75M | $776.71M | $776.38M |
| Intangible Assets | - | - | - | - | - | $92.00K | $367.00K |
| Long-term Investments | $54.62M | $50.73M | $45.40M | $45.92M | $45.29M | $42.78M | $41.41M |
| Other Non-current Assets | $112.52M | $121.78M | $108.37M | $124.48M | $117.87M | $118.41M | $114.49M |
| Total Assets | $1.87B | $1.86B | $1.84B | $1.71B | $1.72B | $1.71B | $1.70B |
| Accounts Payable | $32.31M | $29.34M | $24.06M | $23.19M | $22.47M | $22.49M | $18.84M |
| Short-term Debt | - | - | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M |
| Accrued Liabilities | $114.62M | $74.31M | $55.89M | $50.66M | $79.81M | $57.74M | $68.94M |
| Deferred Revenue | $187.37M | $171.71M | $171.78M | $165.36M | $156.90M | $149.26M | $143.54M |
| Total Current Liabilities | $849.22M | $770.61M | $343.24M | $331.32M | $380.29M | $337.22M | $315.12M |
| Long-term Debt | $2.66B | $2.38B | $2.51B | $2.41B | $2.19B | $2.10B | $2.03B |
| Other Non-current Liabilities | $89.36M | $87.53M | $82.57M | $86.47M | $84.29M | $77.56M | $74.45M |
| Total Liabilities | $3.61B | $3.26B | $2.96B | $2.84B | $2.68B | $2.54B | $2.44B |
| Retained Earnings | $4.55B | $4.40B | $4.22B | $4.05B | $3.90B | $3.77B | $3.64B |
| Treasury Stock | $7.54B | $7.00B | $6.49B | $6.29B | $6.14B | $5.81B | $5.56B |
| Total Stockholders Equity | $-1.75B | $-1.40B | $-1.12B | $-1.14B | $-962.68M | $-829.31M | $-735.66M |
| Total Liabilities & Equity | $1.87B | $1.86B | $1.84B | $1.71B | $1.72B | $1.71B | $1.70B |
| Breakdown | Q4 2025 (Sep 30, 2025) |
Q3 2025 (Jun 30, 2025) |
Q2 2025 (Mar 31, 2025) |
Q1 2025 (Dec 31, 2024) |
Q4 2024 (Sep 30, 2024) |
Q3 2024 (Jun 30, 2024) |
Q2 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $155.01M | $496.93M | $162.62M | $152.53M | $135.69M | $126.26M | $129.80M |
| Depreciation & Amortization | $4.02M | $10.93M | $6.95M | $3.54M | $3.81M | $10.01M | $6.18M |
| Stock-based Compensation | $32.38M | $124.29M | $41.70M | $40.65M | $39.98M | $42.44M | $35.45M |
| Deferred Income Tax | $-13.06M | $-19.43M | $-12.78M | $-5.95M | $-8.32M | $-19.01M | $-13.04M |
| Change in Receivables | $67.59M | $32.78M | $66.72M | $-57.37M | $-13.54M | $47.68M | $72.66M |
| Change in Payables | $5.57M | $4.28M | $1.80M | $841.00K | $-116.00K | $3.43M | $-579.00K |
| Operating Cash Flow | $223.67M | $555.14M | $268.92M | $194.00M | $226.48M | $406.49M | $193.16M |
| Capital Expenditure | $4.17M | $4.75M | $2.96M | $841.00K | $1.75M | $7.13M | $5.40M |
| Purchases of Investments | $832.00K | $5.66M | $4.78M | $2.15M | $511.00K | $17.86M | $16.83M |
| Investing Cash Flow | $-13.33M | $-30.39M | $-19.88M | $-8.94M | $-7.56M | $-20.43M | $-12.04M |
| Stock Repurchased | $547.98M | $866.52M | $379.74M | $162.58M | $323.53M | $498.17M | $243.47M |
| Financing Cash Flow | $-263.54M | $-486.79M | $-247.72M | $-144.22M | $-227.94M | $-364.98M | $-183.22M |
| Net Change in Cash | $-54.91M | $38.38M | $-4.03M | $33.59M | $-5.38M | $19.27M | $-1.11M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Jun 30, 2025
Condensed Consolidated Statements of Operations
| Description | Jun 30, 2025 | Jun 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $536.41M | $447.85M | $1.48B | $1.26B |
| Cost of Revenue | $87.57M | $88.22M | $262.55M | $258.63M |
| Operating Expenses | $273.90M | $257.60M | $787.42M | $727.27M |
| Research & Development | $47.21M | $44.22M | $137.39M | $127.73M |
| Selling General & Admin | $139.11M | $124.88M | $387.48M | $340.08M |
| Operating Income | $262.52M | $190.25M | $687.69M | $536.45M |
| Interest Expense | $32.90M | $26.87M | $101.11M | $91.71M |
| Other Income/Expense | $7.37M | $3.94M | $6.21M | $11.31M |
| Income Before Tax | $236.99M | $167.32M | $600.14M | $470.64M |
| Income Tax Expense | $55.20M | $41.06M | $103.20M | $93.52M |
| Net Income | $181.79M | $126.26M | $496.93M | $377.12M |
| Basic EPS | 7.49 | 5.12 | 20.41 | 15.24 |
| Diluted EPS | 7.40 | 5.05 | 20.12 | 15.01 |
| Basic Shares Outstanding | $24.28M | $24.65M | $24.35M | $24.74M |
| Diluted Shares Outstanding | $24.57M | $25.02M | $24.70M | $25.13M |
Condensed Consolidated Balance Sheets
| Description | Jun 30, 2025 | Sep 30, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $189.05M | $150.67M |
| Accounts Receivable | $454.11M | $426.64M |
| Other Current Assets | $66.69M | $40.10M |
| Total Current Assets | $709.84M | $617.41M |
| Goodwill | $785.45M | $782.75M |
| Long-term Investments | $50.73M | $45.29M |
| Other Non-current Assets | $121.78M | $117.87M |
| Total Assets | $1.86B | $1.72B |
| Accounts Payable | $29.34M | $22.47M |
| Accrued Liabilities | $74.31M | $79.81M |
| Deferred Revenue | $171.71M | $156.90M |
| Total Current Liabilities | $770.61M | $380.29M |
| Long-term Debt | $2.38B | $2.19B |
| Other Non-current Liabilities | $87.53M | $84.29M |
| Total Liabilities | $3.26B | $2.68B |
| Retained Earnings | $4.40B | $3.90B |
| Treasury Stock | $7.00B | $6.14B |
| Total Stockholders Equity | $-1.40B | $-962.68M |
| Total Liabilities & Equity | $1.86B | $1.72B |
Condensed Consolidated Statements of Cash Flows
| Description | Jun 30, 2025 | Jun 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $181.79M | $126.26M | $496.93M | $377.12M |
| Depreciation & Amortization | - | - | $10.93M | $10.01M |
| Stock-based Compensation | $41.93M | $42.44M | $124.29M | $109.46M |
| Deferred Income Tax | - | - | $-19.43M | $-19.01M |
| Change in Receivables | - | - | $32.78M | $47.68M |
| Change in Payables | - | - | $4.28M | $3.43M |
| Operating Cash Flow | - | - | $555.14M | $406.49M |
| Capital Expenditure | - | - | $4.75M | $7.13M |
| Purchases of Investments | - | - | $5.66M | $17.86M |
| Investing Cash Flow | - | - | $-30.39M | $-20.43M |
| Stock Repurchased | - | - | $866.52M | $498.17M |
| Financing Cash Flow | - | - | $-486.79M | $-364.98M |
| Net Change in Cash | - | - | $38.38M | $19.27M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.